drugset / Trial / NCT02455154

Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy

NCT02455154 ↗

Phase 2 Completed 278 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedParallel-groupOpen-labelPrevention

Summary

To test the efficacy of two Traditional Chinese Medicine in preventing osteoporosis in patients receiving adjuvant endocrine therapy.

Timeline

Start
2015-05
Primary completion
2019-02
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Xianlinggubao Unknown 0.5 g Oral
Comparator Zhongyaofufang Unknown — Oral
Comparator Letrozole Other / unclassified 2.5 mg Oral